Telemetric Continuous Glucose Monitoring During the COVID-19 Pandemic in Isolated Hospitalized Patients in Denmark: A Randomized Controlled Exploratory Trial,Diabetes Technology & Therapeutics

当前位置： X-MOL 学术 › Diabetes Technol. Ther. › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

Telemetric Continuous Glucose Monitoring During the COVID-19 Pandemic in Isolated Hospitalized Patients in Denmark: A Randomized Controlled Exploratory Trial
Diabetes Technology & Therapeutics ( IF 5.7 ) Pub Date : 2022-01-31 , DOI: 10.1089/dia.2021.0291
Carina Kirstine Klarskov ₁ , Nicole Avlund Windum ₁ , Mikkel Thor Olsen ₁ , Arnold Matovu Dungu ₂ , Andreas Kryger Jensen _{3,

4} , Birgitte Lindegaard _{2,

5} , Ulrik Pedersen-Bjergaard _{1,

5} , Peter Lommer Kristensen _{1,

5}

Affiliation

Objective: To investigate whether telemetric continuous glucose monitoring (CGM) in hospitalized and isolated patients with diabetes mellitus and coronavirus disease 2019 (COVID-19) is associated with better glycemic outcomes and fewer patient health care worker contacts compared to blood glucose monitoring by traditional point-of-care (POC) glucose testing and to investigate the user aspect of implementing a CGM-system in-hospital.

中文翻译：

丹麦隔离住院患者 COVID-19 大流行期间遥测连续血糖监测：一项随机对照探索性试验

目的：研究与传统点血糖监测相比，对住院和隔离的糖尿病和冠状病毒病 2019 (COVID-19) 患者进行遥测连续血糖监测 (CGM) 是否与更好的血糖结果和更少的患者医护人员接触相关护理 (POC) 葡萄糖测试并调查在医院实施 CGM 系统的用户方面。

更新日期：2022-02-11

点击分享查看原文

点击收藏

阅读更多本刊最新论文本刊介绍/投稿指南11